Onconetix Inc stock is traded at $2.89, with a volume of 42,863. It is down -8.54% in the last 24 hours and down -28.89% over the past month. Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
Previous Close:
$3.16
Open:
$3.31
24h Volume:
42,863
Relative Volume:
0.29
Market Cap:
$2.37M
Revenue:
$735.20K
Net Income/Loss:
-$9.70M
P/E Ratio:
-
EPS:
-$435.73
Net Cash Flow:
-$9.80M
1W Performance:
-9.97%
1M Performance:
-28.89%
6M Performance:
-73.73%
1Y Performance:
-99.75%
1-Day Range:
$2.85$3.31
1-Week Range:
$2.76$3.37
52-Week Range:
$2.76$1,610.00
Onconetix Inc Stock (ONCO) Company Profile
Name
Onconetix IncSector
HealthcareIndustry
BiotechnologyPhone
513-620-4101Address
201 E. FIFTH STREET, CINCINNATI, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS